Contemporary Time Trends in Use of Antiplatelet Agents Among Patients with Acute Coronary Syndrome and Comorbid Diabetes Mellitus or Chronic Kidney Disease

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Pharmacotherapy

• Publication date

  2017-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/phar.2018PMID 28833345
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Valproate for agitation in critically ill patients: A retrospective study

  2017cited by this paper
• Valproate Protein Binding Is Highly Variable in ICU Patients and Not Predicted by Total Serum Concentrations: A Case Series and Literature Review

  2017cited by this paper
• What is the place of clonidine in anesthesia? Systematic review and meta-analyses of randomized controlled trials.

  2017cited by this paper
• Contemporary Trends in Oral Antiplatelet Agent Use in Patients Treated with Percutaneous Coronary Intervention for Acute Coronary Syndrome.

  2017cited by this paper
• Systematic review and meta-analysis of optimal P2Y12 blockade in dual antiplatelet therapy for patients with diabetes with acute coronary syndrome

  2016cited by this paper
• Contemporary use of ticagrelor in patients with acute coronary syndrome: insights from Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART).

  2016cited by this paper
• 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

  2016cited by this paper
• Volatile Anesthetics. Is a New Player Emerging in Critical Care Sedation?

  2016cited by this paper
• Ketamine for analgosedation in critically ill patients.

  2016cited by this paper
• Trends in P2Y12 Inhibitor Use in Patients Referred for Invasive Evaluation of Coronary Artery Disease in Contemporary US Practice.

  2016cited by this paper
• Efficacy of &agr;2-Agonists for Sedation in Pediatric Critical Care: A Systematic Review*

  2016cited by this paper
• Emerging Role of Melatonin and Melatonin Receptor Agonists in Sleep and Delirium in Intensive Care Unit Patients

  2016cited by this paper
• A Randomized Placebo-controlled Trial of Clonidine Impact on Sedation of Mechanically Ventilated ICU Patients

  2015cited by this paper
• Transition from Dexmedetomidine to Enteral Clonidine for ICU Sedation: An Observational Pilot Study

  2015cited by this paper
• Valproic Acid for Treatment of Hyperactive or Mixed Delirium: Rationale and Literature Review.

  2015cited by this paper
• Use of Antiepileptic Drugs in Patients with Chronic Kidney Disease and End Stage Renal Disease

  2015cited by this paper
• Adjunctive Valproic Acid in Management-Refractory Hyperactive Delirium: A Case Series and Rationale.

  2015cited by this paper
• Platelet reactivity after receiving clopidogrel compared with ticagrelor in patients with kidney failure treated with hemodialysis: a randomized crossover study.

  2015cited by this paper
• Early Clopidogrel Versus Prasugrel Use Among Contemporary STEMI and NSTEMI Patients in the US: Insights From the National Cardiovascular Data Registry

  2014cited by this paper
• Use of Medicare Data to Identify Coronary Heart Disease Outcomes in the Women’s Health Initiative

  2014cited by this paper
• 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

  2014cited by this paper
• Prasugrel versus clopidogrel for acute coronary syndromes without revascularization

  2013cited by this paper
• Clinical Practice Guidelines for the Management of Pain, Agitation, and Delirium in Adult Patients in the Intensive Care Unit

  2013cited by this paper
• Clonidine Induces Sedation Through Acting on the Perifornical Area and the Locus Coeruleus in Rats

  2013cited by this paper
• Benzodiazepine Versus Nonbenzodiazepine-Based Sedation for Mechanically Ventilated, Critically Ill Adults: A Systematic Review and Meta-Analysis of Randomized Trials

  2013cited by this paper
• Antiplatelet agents for chronic kidney disease

  2013cited by this paper
• Phenobarbital for acute alcohol withdrawal: a prospective randomized double-blind placebo-controlled study.

  2013cited by this paper
• Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.

  2012cited by this paper
• How theories evolved concerning the mechanism of action of barbiturates

  2012cited by this paper
• Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management.

  2012cited by this paper
• Appropriateness of coronary revascularization for patients without acute coronary syndromes.

  2012cited by this paper
• How phenobarbital revolutionized epilepsy therapy: The story of phenobarbital therapy in epilepsy in the last 100 years

  2012cited by this paper
• New insights on the mechanisms of valproate-induced hyperammonemia: inhibition of hepatic N-acetylglutamate synthase activity by valproyl-CoA.

  2011cited by this paper
• A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial

  2011cited by this paper
• 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).

  2011cited by this paper
• Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial

  2010cited by this paper
• Use of Evidence-Based Therapies in Short-Term Outcomes of ST-Segment Elevation Myocardial Infarction and Non–ST-Segment Elevation Myocardial Infarction in Patients With Chronic Kidney Disease: A Report From the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network R

  2010cited by this paper
• Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function: Results From the Platelet Inhibition and Patient Outcomes (PLATO) Trial

  2010cited by this paper
• CYP2D6 Mediates 4-Hydroxylation of Clonidine In Vitro: Implication for Pregnancy-Induced Changes in Clonidine Clearance

  2010cited by this paper
• Faculty Opinions recommendation of Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction

  2009cited by this paper
• The Interaction of the Neuroprotective Compounds Riluzole and Phenobarbital with AMPA-Type Glutamate Receptors: A Patch-Clamp Study

  2009cited by this paper
• Effects of clonidine and midazolam premedication on bispectral index and recovery after elective surgery

  2009cited by this paper
• The Effect of Carbapenem Antibiotics on Plasma Concentrations of Valproic Acid

  2009cited by this paper
• Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies

  2008cited by this paper
• Determination of a Lorazepam Dose Threshold for Using the Osmol Gap to Monitor for Propylene Glycol Toxicity

  2008cited by this paper
• Distinct absorption characteristics of oral formulations of valproic acid/divalproex available in the United States.

  2007cited by this paper
• Interaction Between Valproate and Meropenem: A Retrospective Study

  2007cited by this paper
• Prasugrel versus clopidogrel in patients with acute coronary syndromes.

  2007cited by this paper
• Valproic acid-induced pancreatitis: 16 new cases and a review of the literature

  2007cited by this paper
• Identification of individuals with CKD from Medicare claims data: a validation study.

  2005cited by this paper
• Adjunctive valproic acid for delirium and/or agitation on a consultation-liaison service: a report of six cases.

  2005cited by this paper
• Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records.

  2004cited by this paper
• Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization.

  2004cited by this paper
• Kinetics of phenobarbital in normal subjects and epileptic patients

  2004cited by this paper
• Propylene Glycol‐Associated Renal Toxicity from Lorazepam Infusion

  2003cited by this paper
• Pharmacological and Therapeutic Properties of Valproate

  2002cited by this paper
• Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy.

  2002cited by this paper
• Co-morbidity data in outcomes research: are clinical data derived from administrative databases a reliable alternative to chart review?

  2000cited by this paper
• Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action.

  1999cited by this paper
• A Mechanistic Approach to Antiepileptic Drug Interactions

  1998cited by this paper
• Oral clonidine for sedation and analgesia in a burn patient.

  1998cited by this paper
• Antiepileptic Drug Mechanisms of Action

  1993cited by this paper
• A hypnotic response to dexmedetomidine, an alpha 2 agonist, is mediated in the locus coeruleus in rats.

  1992cited by this paper
• Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist.

  1988cited by this paper
• Clinical Pharmacokinetics of Valproic Acid — 1988

  1988cited by this paper
• Valproic Acid and Metabolites: Pharmacological and Toxicological Studies

  1984cited by this paper
• The Hepatotoxicity of Valproic Acid and Its Metabolites in Rats. I. Toxicologic, Biochemical and Histopathologic Studies

  1984cited by this paper
• Relationship between the cardiovascular effects and steady-state kinetics of clonidine in hypertension

  1984cited by this paper
• Discontinuation Syndrome Following Cessation of Treatment with Clonidine and Other Antihypertensive Agents

  1980cited by this paper
• Pharmacokinetics and side-effects of clonidine

  1978cited by this paper
• Pharmacokinetics and concentration‐effect relationships of intravenous and oral clonidine

  1977cited by this paper
• Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline.

  1977cited by this paper

• The effects of CYP2C19 genotype polymorphism and clopidogrel resistance on ischemic event occurrence in patients with peripheral arterial disease undergoing revascularization: A prospective cohort study.

  2024cites this paper
• Newer P2Y12 Inhibitors vs Clopidogrel in Acute Myocardial Infarction With Cardiac Arrest or Cardiogenic Shock: A Systematic Review and Meta-analysis.

  2022cites this paper
• Revascularization in Patients With Non-ST Elevation Myocardial Infarction and Advanced Chronic Kidney Disease.

  2022cites this paper
• Physician and Hospital Utilization of P2Y12 Inhibitors in ST-Segment–Elevation Myocardial Infarction in the United States

  2020cites this paper
• One‐year efficacy and safety of prasugrel and ticagrelor in patients with acute coronary syndromes: Results from a prospective and multicentre ACHILLES registry

  2020cites this paper
• TicagRelor Or Clopidogrel in severe or terminal chronic kidney patients Undergoing PERcutaneous coronary intervention for acute coronary syndrome: The TROUPER trial.

  2020cites this paper
• Cyp2C19*2 Polymorphism Related to Clopidogrel Resistance in Patients With Coronary Heart Disease, Especially in the Asian Population: A Systematic Review and Meta-Analysis

  2020cites this paper
• Thromboembolic and Bleeding Risk in Atrial Fibrillation Patients with Chronic Kidney Disease: Role of Anticoagulation Therapy

  2020cites this paper
• Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y12 Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial

  2019cites this paper
• Safety of Dual‐Antiplatelet Therapy After Myocardial Infarction Among Patients With Chronic Kidney Disease

  2019cites this paper
• DEPTH P 2 Y 12-ADP Receptor Blockade in Chronic Kidney Disease Patients With Acute Coronary Syndromes Review of the Current Evidence

  2018cites this paper
• P2Y12-ADP Receptor Blockade in Chronic Kidney Disease Patients With Acute Coronary Syndromes.

  2018cites this paper
• Chronic Kidney Disease and Third‐Generation P2Y12 Inhibitors Use in Patients With Acute Coronary Syndrome: Impact on the Prognosis at 1 Year

  2018cites this paper